Paragonix Presenting Expansive Organ Transplant Research at the International Society of Heart and Lung Transplantation 44th Annual Meeting
21 Mar 2024
AHAClinical Study
Multiple abstracts to be presented at the 2024 ISHLT Annual Meeting and Scientific Sessions highlight the growing body of clinical evidence illustrating the post-transplant impact of Paragonix advanced organ preservation devices on patient outcomes.
WALTHAM, Mass.--(BUSINESS WIRE)-- Paragonix Technologies, Inc., a pioneer in organ transplant products and services, is honored to announce the forthcoming release of new clinical data supporting the use of controlled hypothermic preservation and clinical services. These presentations compare and analyze post-transplant outcomes of patients, presented by a multi-center panel of clinical investigators representing the GUARDIAN Clinical Registries at the 44th ISHLT Annual Meeting and Scientific Sessions, located at the Prague Congress Center in Prague, Czech Republic from April 10-13, 2024.
Clinical investigators will be sharing data and research related to Paragonix heart and lung devices in five oral presentations and four posters throughout the conference, including:
Presentation: Largest Real-World Multi-Center Study Outcomes Reported with Controlled Hypothermic Preservation of Donor Lungs
April 10, 2024, 4:00 PM - 4:10 PM - South Hall 1
Presentation: Improved 2-Year Heart Transplant Survival with Moderate Hypothermic Donor Heart Preservation in the Guardian Heart Registry
April 12, 2024, 10:45 AM - 10:55 AM - South Hall 1
Mini Presentation: Determination of the Optimal Temperature for Organ Preservation through Analysis of the Guardian Registry
April 12, 2024, 4:42 PM - 4:46 PM - Congress Hall
Mini Presentation: Reduced Risk of Cardiovascular-Related Death Associated with Moderate Hypothermic Donor Heart Preservation in the Guardian Heart Registry
April 12, 2024, 4:54 PM - 4:58 PM - Congress Hall
Mini Presentation: Extension of Ischemic Time with Controlled Hypothermic Lung Preservation Facilitates Time-Shifting Practice and Expansion of the Donor Pool
April 12, 2024, 4:54 PM - 4:58 PM - Forum Hall
Poster: Building the Future: Novel Procurement Network Model to Support Rapidly Growing Cardiothoracic Transplantation Volumes
April 10, 2024, 6:00 PM - 7:00 PM, Poster Hall
Poster: An Analysis of ECMO Use Post-Transplant in the GUARDIAN Heart Registry
April 11, 2024, 4:30 PM - 5:30 PM - Poster Hall
Poster: Global Pediatric Experience Using Controlled Moderate Hypothermia: A Subgroup Analysis of the GUARDIAN Heart Registry
April 12, 2024, 4:30 PM - 5:30 PM - Poster Hall
Poster: Improved Post-Transplant Outcomes in Blood Group O Recipients Through Controlled Hypothermic Preservation
April 12, 2024, 4:30 PM - 5:30 PM - Poster Hall
Additionally, Paragonix will be hosting an Industry Symposium, titled “Reimagined Clinical Standards: Transformative Innovations in Organ Preservation,” held at ISHLT on Friday, April 12 at 11:45 PM CET in South Hall 2. The event will feature a panel of three leading thoracic surgeons and investigators of the GUARDIAN Registry as they explore the scientific foundation of advanced organ preservation and examine the associated impact on patient outcomes.
"We're thrilled by the extensive studies being presented at this year’s conference that strongly support the development of new and superior organ preservation technologies,” said Dr. Lisa Anderson, CEO and President of Paragonix. "It's an honor to have the opportunity to share and celebrate the critical research our esteemed colleagues present each year, as they pave a new way forward and redefine the standard of care in organ transportation."
To visit the Paragonix Technologies exhibit and meet members of their team at ISHLT, visit booth #20. For more information about Paragonix, visit .
About Paragonix Technologies
Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation.
Paragonix Technologies provides Advanced Organ Preservation (“AOP”) devices that safeguard donor organs during the journey between donor and recipient patients. Our FDA-cleared and CE-marked devices incorporate clinically proven and medically trusted cold preservation techniques that allow unprecedented physical and thermal protection to the organ during transit. All Paragonix AOP devices are natively integrated with our novel digital app, delivering real-time organ tracking data and monitoring logistics for transplant teams seeking a secure and centralized solution. For more information, visit .
Connect with us on LinkedIn: Paragonix Technologies
Follow us on Twitter: @ParagonixSherpa
Like Us on Facebook: Paragonix SherpaPak
L-594 Ver. 0
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.